Precision medicine, cell and gene therapies, decentralized trials, real-world data, and the promise of artificial intelligence and machine learning are just a few of the reasons to be excited about the future of clinical research....
The US Food and Drug Administration (FDA) is recommending sponsors include a plan to increase diversity when proposing clinical trial designs for investigational products to agency reviewers....
Some shared observations and recommendations highlighting examples that may bring decentralized and hybrid trials to a more tangible and realistic view and make them more executable....
A new clinical trial led by researchers at the University of Wisconsin-Madison could increase access to eye screenings for patients in rural Wisconsin....
In the arena of clinical research, gender equity accelerates research excellence: we need multiple perspectives and all the brain power we can muster to maximize research productivity and quality....
Moderna announced that positive safety and efficacy results from its 'KidCOVE' COVID-19 vaccine study open the door for the company to request emergency use authorization from the FDA to vaccinate children under 6 years of age....
Drugs that control blood pressure and lower cholesterol, among others, nay help patients derive greater benefit from cancer treatment....
In a little over 18 months, UW-Madison has conducted COVID vaccine and treatment trials in all age groups (ages 7 months- 96 years old). These trials are a representation of all people (race, religion, sex) in Wisconsin- nearly 700 participants....
New clinical trial design strategies could spell a more promising future in rare disease drug development. ...
Until we have better inclusion of participants with diverse demographics and behaviors – and can analyze that data in conjunction with prognostic data – we won’t know the effectiveness of a product for these large, underrepresented populations....
